DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025

About this update from Diamedica Therapeutics Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2000,"height":631,"url":"https://media.zenfs.com/en/business-wire.com/cd26a0103c4996e81ffc31f193358475"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zZZp39WEuJHIGYJF81wZBg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwMztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cd26a0103c4996e81ffc31f193358475","width":960,"height":303},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/kC_ZqiJcLxMeYjaQWuT1HQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/cd26a0103c4996e81ffc31f193358475","width":1200,"height":379}},"lazy":false},{"type":"text","content":"MINNEAPOLIS, May 07, 2025--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, announced today that its first quarter 2025 financial results will be released after the markets close on Tuesday, May 13th. DiaMedica will host a live conference call on Wednesday, May 14th at 7:00 AM Central Time to provide a business update and discuss financial results.","length":488,"tagName":"p"},{"type":"text","content":"Conference Call details:","length":24,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"width:121px;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"width:291px;","val":[{"type":"text","content":"Wednesday, May 14, 2025","length":23,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:121px;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"width:291px;","val":[{"type":"text","content":"8:00 AM ET / 7:00 AM CT","length":23,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:121px;","val":[{"type":"text","content":"Web access:","length":11,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"width:291px;","val":[{"type":"text","content":"https://app.webinar.net/24NpV0mjklG","length":35,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:121px;","val":[{"type":"text","...

More updates from Diamedica Therapeutics Inc.